Medicare Enrolled
Dr. Thomas Kurian, M.D.
Neurology with Special Qualifications in Child Neurology Physician · Valencia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kurian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kurian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kurian
Dr. Thomas Kurian is a neurology with special qualifications in child neurology physician in Valencia, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kurian performed 2,033 Medicare services across 1,123 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kurian received a total of $22,438 from 79 pharmaceutical and/or device companies across 1157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology with special qualifications in child neurology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kurian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 29% volume in CA
$22,438 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,033
Medicare services
Top 29% in CA for neurology with special qualifications in child neurology physician
1,123
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
762 | $97 | $223 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
353 | $97 | $143 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
248 | $64 | $139 |
| New patient office visit, complex (60-74 min) | 180 | $169 | $306 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
168 | $137 | $304 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
104 | $177 | $386 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
95 | $110 | $232 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
92 | $343 | $488 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $74 | $127 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,438
Total received (2018-2024)
Avg $3,205/year across 7 years
Top 10% in CA for neurology with special qualifications in child neurology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,157
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,221 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$216 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,399
2023
$4,266
2022
$4,435
2021
$2,922
2020
$1,838
2019
$2,548
2018
$1,030
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$791
Eisai Inc.
$472
UCB, Inc.
$418
Lilly USA, LLC
$397
MDD US Operations, LLC
$379
Neurelis, Inc.
$343
Teva Pharmaceuticals USA, Inc.
$300
SK Life Science, Inc.
$291
PFIZER INC.
$249
TG Therapeutics, Inc.
$236
Abbott Laboratories
$150
Alnylam Pharmaceuticals Inc.
$144
Celgene Corporation
$134
Genentech USA, Inc.
$105
Lundbeck LLC
$101
EMD Serono, Inc.
$100
Novartis Pharmaceuticals Corporation
$97
Merz Pharmaceuticals, LLC
$80
Octapharma USA, Inc.
$78
AstraZeneca Pharmaceuticals LP
$74
Otsuka America Pharmaceutical, Inc.
$72
Neurocrine Biosciences, Inc.
$60
CSL Behring
$59
ACADIA Pharmaceuticals Inc
$49
Kyowa Kirin, Inc.
$49
Sumitomo Pharma America, Inc.
$42
ARGENX US, INC.
$32
Azurity Pharmaceuticals, Inc.
$25
Grifols USA, LLC
$22
LivaNova USA, Inc.
$18
BioMarin Pharmaceutical Inc.
$17
Amgen Inc.
$13
Top 3 companies account for 31.1% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,507
Teva Pharmaceuticals USA, Inc.
$1,660
UCB, Inc.
$1,492
Lilly USA, LLC
$1,248
Novartis Pharmaceuticals Corporation
$972
SK Life Science, Inc.
$935
Biogen, Inc.
$844
Amgen Inc.
$735
MDD US Operations, LLC
$720
Genentech USA, Inc.
$677
Eisai Inc.
$566
Neurelis, Inc.
$561
GENZYME CORPORATION
$530
Sunovion Pharmaceuticals Inc.
$523
Allergan, Inc.
$479
Supernus Pharmaceuticals, Inc.
$426
PFIZER INC.
$424
EMD Serono, Inc.
$409
Neurocrine Biosciences, Inc.
$351
Biohaven Pharmaceuticals, Inc.
$340
Greenwich Biosciences, Inc.
$325
AbbVie Inc.
$296
Celgene Corporation
$285
AstraZeneca Pharmaceuticals LP
$279
Alnylam Pharmaceuticals Inc.
$260
TG Therapeutics, Inc.
$259
Octapharma USA, Inc.
$251
UPSHER-SMITH LABORATORIES LLC
$249
Lundbeck LLC
$249
TG THERAPEUTICS, INC.
$246
Acorda Therapeutics, Inc
$219
Avanir Pharmaceuticals, Inc.
$194
Abbott Laboratories
$190
LivaNova USA, Inc.
$190
ARGENX US, INC.
$161
Kyowa Kirin, Inc.
$152
CSL Behring
$146
Akcea Therapeutics, Inc.
$141
EISAI INC.
$132
Mallinckrodt Hospital Products Inc.
$130
Mallinckrodt LLC
$112
Alexion Pharmaceuticals, Inc.
$111
ACADIA Pharmaceuticals Inc
$108
Chiesi USA, Inc.
$100
Biohaven Pharmaceutical Holding Company Ltd.
$85
Sumitomo Pharma America, Inc.
$81
Merz Pharmaceuticals, LLC
$80
Otsuka America Pharmaceutical, Inc.
$72
Allergan Inc.
$68
IMPEL PHARMACEUTICALS INC.
$66
Almatica Pharma LLC
$65
ARBOR PHARMACEUTICALS, INC.
$63
Amneal Pharmaceuticals LLC
$63
Assertio Therapeutics, Inc.
$51
ASSERTIO THERAPEUTICS, Inc.
$40
Promius Pharma LLC
$39
Sobi, Inc
$39
Collegium Pharmaceutical, Inc.
$37
Bayer HealthCare Pharmaceuticals Inc.
$36
Upsher-Smith Laboratories LLC
$26
Mallinckrodt Enterprises LLC
$26
JAZZ PHARMACEUTICALS INC.
$25
Azurity Pharmaceuticals, Inc.
$25
Mitsubishi Tanabe Pharma America, Inc.
$23
Grifols USA, LLC
$22
Impax Laboratories, Inc.
$22
Scilex Pharmaceuticals Inc.
$21
Egalet US Inc
$21
PORTOLA PHARMACEUTICALS, INC.
$20
CATALYST PHARMACEUTICALS, INC.
$20
Exeltis, USA Inc.
$19
Adamas Pharmaceuticals, Inc.
$19
BioMarin Pharmaceutical Inc.
$17
Ceribell, Inc.
$17
Mylan Pharmaceuticals Inc.
$14
Boston Scientific Corporation
$13
Jazz Pharmaceuticals Inc.
$12
Dynasplint Systems Inc.
$9
Travere Therapeutics, Inc.
$1
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Brineura · Briviact · CAMBIA · CLEVIPREX · COMIRNATY · Cambia · Ceribell Rapid Resonse EEG · Cholbam · DAYBUE · Dynasplint · ELYXYB - celecoxib · EMGALITY · ENSITE PRECISION · Enspryng · Epidiolex · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · SUPERION · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · XADAGO · XYREM · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology with special qualifications in child neurology physician in CA.
Geographic Context
Neurology with special qualifications in child neurology physicians within 10 mi
28
Per 100K population
0.3
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kurian is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kurian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kurian performed 762 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kurian receive payments from pharmaceutical companies?
Yes. Dr. Kurian received a total of $22,438 from 79 companies across 1,157 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kurian's costs compare to other neurology with special qualifications in child neurology physicians in Valencia?
Dr. Kurian's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kurian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Neurology With Special Qualifications In Child Neurology Physicians in Valencia
Browse neurology with special qualifications in child neurology physicians in Valencia ranked by procedure volume and transparency data.
Highest volume
Top Neurology With Special Qualifications In Child Neurology Physicians in CA
Neurology with special qualifications in child neurology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurology With Special Qualifications In Child Neurology Physicians in CA
Which CA neurology with special qualifications in child neurology physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology